Recent contributions to transplantation at the University of Cincinnati.

Keyphrases

• Size Reduction 100%
• Cincinnati 100%
• Transplantation 100%
• Liver 66%
• Unresponsiveness 66%
• Graft Loss 66%
• Donor-specific 66%
• Control Method 33%
• Immunosuppression 33%
• Cholesterol 33%
• High Incidence 33%
• Blood Pressure 33%
• Increased Dose 33%
• Kidney Transplantation 33%
• Low-density Lipoprotein 33%
• Vulva 33%
• Diabetic 33%
• Clinical Investigation 33%
• Primary Nonfunction 33%
• Graft Survival 33%
• Sarcoma 33%
• Immunosuppressed 33%
• Prednisone 33%
• Liver Disease 33%
• Lymphoma 33%
• Transplant Recipients 33%
• Low-income Patients 33%
• Immunosuppressive Therapy 33%
• Infection Control 33%
• Retreatment 33%
• Hepatic Metabolism 33%
• OKT3 33%
• Living Donor 33%
• Biliary Atresia 33%
• Whole Organ 33%
• Tumor Registry 33%
• Immunological Surveillance 33%
• Economic Consequences 33%
• Single Donor 33%
• Kaposi Sarcoma 33%
• Insulin Requirement 33%
• Pediatric Liver Transplant 33%
• Ketoconazole 33%
• Tumor Patients 33%
• All Pediatric 33%
• Cadaveric Donor 33%
• Transplanted Liver 33%
• Drug Absorption 33%
• CNS Tumors 33%
• Donor Kidney 33%
• Liver Patient 33%

Medicine and Dentistry

• Cancer 100%
• Pediatrics 40%
• Transplantation 40%
• Immunosuppressive Treatment 40%
• Graft Failure 40%
• Neoplasm 20%
• Liver Graft 20%
• Diabetes Mellitus 20%
• End Stage Renal Disease 20%
• Blood Pressure 20%
• Systemic Lupus Erythematosus 20%
• Low-Density Lipoprotein 20%
• Kidney Transplantation 20%
• Cadaver 20%
• Graft Survival 20%
• Population 20%
• Prednisone 20%
• Liver Disease 20%
• Retreatment 20%
• Biliary Atresia 20%
• Vulva 20%
• Central Nervous System Tumor 20%
• Kaposi Sarcoma 20%
• Connective Tissue Cancer 20%
• Immunological Monitoring 20%